The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 randomized study of chemoimmunotherapy with or without eflornithine (DFMO) in relapsed/refractory neuroblastoma: A Children’s Oncology Group (COG) report.
 
Margaret Macy
Stock and Other Ownership Interests - GE Healthcare; Johnson & Johnson; Varian Medical Systems
Consulting or Advisory Role - EUSA Pharma; Kestrel Therapeutics; Kestrel Therapeutics; Ymabs Therapeutics Inc
Research Funding - Abbvie (Inst); Actuate Therapeutics (Inst); Bayer (Inst); Ignyta (Inst); Jubilant DraxImage (Inst); Lilly (Inst); Merck (Inst); Oncternal Therapeutics, Inc (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Patent for non-invasive methods of leukemia cell detection with MRI/MRS - Patent No. 8894975
Travel, Accommodations, Expenses - Bayer
(OPTIONAL) Uncompensated Relationships - Abbvie
 
Arlene Naranjo
Consulting or Advisory Role - Novartis
 
Fan Zhang
No Relationships to Disclose
 
Michael Acord
No Relationships to Disclose
 
Thomas Cash
Consulting or Advisory Role - US WorldMeds; Y-mAbs Therapeutics
Research Funding - Celgene (Inst); Lilly (Inst); Roche/Genentech (Inst)
(OPTIONAL) Uncompensated Relationships - United Therapeutics; Y-mAbs Therapeutics
 
Steven DuBois
Consulting or Advisory Role - Amgen; Bayer; EMD Serono; InhibRx; Jazz Pharmaceuticals
Research Funding - Bayer (Inst); BMS (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Jennie Foster
Consulting or Advisory Role - US WorldMeds; Ymabs Therapeutics Inc
 
Kristin Knight
Consulting or Advisory Role - US World Meds
 
Michael Hogarty
No Relationships to Disclose
 
Rajen Mody
Other Relationship - Jubilant DraxImage; YmAbs Therapeutics Inc
 
Daniel Morgenstern
Honoraria - HMP; Ology Medical Education; Takeda Israel Ltd
Consulting or Advisory Role - Abbvie; Clarity Pharmaceuticals; RayzeBio; Regeneron; US World Meds; Ymabs Therapeutics Inc
Speakers' Bureau - Takeda Israel Ltd; Ymabs Therapeutics Inc
Research Funding - Abbvie (Inst); Bayer (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Cellectar (Inst); Lilly (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Abbvie
(OPTIONAL) Uncompensated Relationships - Oncoheroes Biosciences
 
Marguerite Parisi
No Relationships to Disclose
 
Navin Pinto
Consulting or Advisory Role - Eureka Therapeutics; Novartis
Patents, Royalties, Other Intellectual Property - Patent 20210346431 licensed to Umoja Biotherapeutics
(OPTIONAL) Uncompensated Relationships - US WorldMeds; Y-mAbs Therapeutics
 
C. Reynolds
Honoraria - Recordati
Consulting or Advisory Role - Recordati
Patents, Royalties, Other Intellectual Property - Issued patent on use of APR-246 for treatment of ALT cancers owned by Texas Tech University System
Travel, Accommodations, Expenses - Recordati
(OPTIONAL) Uncompensated Relationships - Aprea Therapeutics; AstraZeneca
 
Michelle Keyel
Travel, Accommodations, Expenses - Ascendis Pharma
 
Barry Shulkin
No Relationships to Disclose
 
David Ziegler
Consulting or Advisory Role - Accendatech; Alexion Pharmaceuticals; Amgen; AstraZeneca/Merck; Bayer; Day One Biopharmaceuticals; FivePhusion; Norgine; Novartis
Research Funding - Accendatech (Inst)
Travel, Accommodations, Expenses - Bayer
 
Rochelle Bagatell
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb/Celgene; Merck KGaA
 
Julie Park
Patents, Royalties, Other Intellectual Property - Patent licensed to Umoja Pharmaceuticals, no monetary value to date
 
Kelly Goldsmith
No Relationships to Disclose